Clearstead Advisors’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.74K Buy
+25
New +$3.71K ﹤0.01% 2211
2026
Q1
Sell
-719
Closed -$57.8K 2248
2025
Q4
$57.8K Buy
719
+477
+197% +$39.9K ﹤0.01% 1340
2025
Q3
$23.6K Hold
242
﹤0.01% 1571
2025
Q2
$16.9K Buy
242
+229
+1,762% +$13.1K ﹤0.01% 1692
2025
Q1
$646 Hold
13
﹤0.01% 2039
2024
Q4
$909 Sell
13
-35
-73% -$2.91K ﹤0.01% 1933
2024
Q3
$5.03K Sell
48
-49
-51% -$5.73K ﹤0.01% 1709
2024
Q2
$13.8K Buy
97
+84
+646% +$9.68K ﹤0.01% 1473
2024
Q1
$1.46K Sell
13
-175
-93% -$20.9K ﹤0.01% 1355
2023
Q4
$24.4K Sell
188
-12
-6% -$1.65K ﹤0.01% 902
2023
Q3
$32.6K Buy
+200
New +$35.2K ﹤0.01% 802

Other funds holding ACLS

Clearstead Advisors's ACLS Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Axcelis (ACLS) in Q2 2026: 25 shares worth $4.74K. The stake represents ﹤0.01% of the portfolio and ranks #2211 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in ACLS as recently as Q4 2025.

Clearstead Advisors first reported a position in ACLS in Q3 2023 and has held it in 11 quarters since. The position peaked at $57.8K in Q4 2025. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Clearstead Advisors held 25 shares of Axcelis worth $4.74K as of Q2 2026.
  • Axcelis was a new Clearstead Advisors position in Q2 2026.
  • Axcelis made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2211 holding.
  • Clearstead Advisors first reported a position in Axcelis in Q3 2023 and has held it in 11 quarters since.
  • Clearstead Advisors's Axcelis position peaked at $57.8K in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.